• About
• Links
• Contact
• Sitemap

Disposable Syringe Markets

This  report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes.

Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses.

The disposable syringe market segments are identified as:

1) total reusable needle and syringe market;

2) total disposable needle and syringe market;

3) prefilled syringes;

4) safety syringes;

5) insulin injector pens;

6) needleless injectors;

7) vaccination injectors;

8) blood collection needles and syringes;

9) hypodermic needles and syringes market;

10) insulin needles and syringes market;

11) specialty needles and syringes market;

12) needleless injector market.

Table of Contents

TABLE OF CONTENTS

 

1.           Introduction          11

• 1.1         Statement of Report            11
• 1.2         About this Report        11
• 1.3         Scope of the Report            11
• 1.4         Objectives            12
• 1.5         Methodology        13
• 1.6         Executive Summary            14

 

2.           Disposable Syringe Markets             16

• 2.1         Overview             16
• 2.2         Infection Control and Safety             17
  • 2.2.1      Needlestick Injuries           17
  • 2.2.2      Availability of Safety Syringes in the U.S. Healthcare Facilities 19
• 2.3         Cost of Safety Syringe        19
• 2.4         Market Expansion               20
• 2.5         Unsafe Injection Practices          20
• 2.6         Hospital Consolidations Pressure Companies to Reduce Prices         20
• 2.7         Strategic Alliance of Needleless Injector Manufacturers             21
• 2.8         Technological Advancements in Disposable Syringes  21
  • 2.8.1      Reconstitution inside Sterile Syringes             21
  • 2.8.2      Plungerless Prefilled Syringes          22
  • 2.8.3      The Disposable UniJect™         22
• 2.9         Award Winning Syringes   22
  • 2.9.1      Episure AutoDetect Epidural Syringe             23
  • 2.9.2      ConfiDose Disposable Autoinjector               23
  • 2.9.3      Humatrope Reconstitution Device    24
  • 2.9.4      Vasceze Plungerless Syringe            24

 

3.           Disposable Syringe Market Segments             25

• 3.1         Overview             25
  • 3.1.1      World Market for Disposable Syringes          25
  • 3.1.2      U.S. Market for Disposable Syringes              27
  • 3.1.3      Disposable Syringe Market in India             29

 

4.           Insulin Syringes    32

• 4.1         Insulin Strengths: U-40 and U-100    32
• 4.2         Market for Insulin Pen        33
• 4.3         Shelf Life of Insulin Pen Cartridges  34
• 4.4         An Update on Insulin Injection Devices          35
  • 4.4.1      Insulin Injection Devices Currently Available in the U.S.           35
  • 4.4.2      Disposable Pens     36
  • 4.4.3      Refillable Pens    36
  • 4.4.4      Pen Needles         36
  • 4.4.5      Benefits and Patient Preferences       37
  • 4.4.6      Disadvantages of Pen Syringes         37
  • 4.4.7      Insulin Pens and the Hospital Bills          38
• 4.5         Insulin Pens for Indian Market from IDC        38
• 4.6         Expansion of Facilities for Insulin Pens by Eli Lilly and Rexam 39
• 4.7         Major Players in Insulin Pens and Syringes       39
  • 4.7.1      Sanofi-Aventis       39
    • 4.7.1.1   Sanofi-Aventis’ Business in Diabetes Care Segment    39
  • 4.7.2      Novo Nordisk      41
    • 4.7.2.1   Novo Nordisk’s Diabetes Care Business in North America        41
    • 4.7.2.2   Novo Nordisk’s International Operations       42
    • 4.7.2.3   Novo Nordisk’s Business in Diabetes Care in Europe        42
  • 4.7.3      Eli Lilly & Co.     43
    • 4.7.3.1   Byetta          43
    • 4.7.3.2   Humulin        44
    • 4.7.3.3   Humalog               45

 

5.           Safety Syringes    46

• 5.1         Available Safety Syringe Technologies          46
  • 5.1.1      Retrofitted Syringes            46
  • 5.1.2      Automatically Retractable Syringes          46
  • 5.1.3      Manually Retractable Syringes         46
• 5.2         Safety Syringe Market        47
• 5.3         Drivers of Safety Syringes       47

 

6.           Prefilled Syringes               48

• 6.1         Types of Prefilled Syringes (PFS)    48
• 6.2         Market for Prefilled Syringes           48
• 6.3         The Rise of Prefilled Syringes          49
• 6.4         Needle Safety for Prefilled Syringes               50
  • 6.4.1      V-OVS NS®        51
  • 6.4.2      Preventis™          51
  • 6.4.3      UltraSafe Passive® Delivery System/ERYPROSafe™ and NUFILSafe™              51
• 6.5         Sterility Maintenance of Prefilled Syringes    52
• 6.6         Compatibility of Drugs with the Components of Prefilled Syringes           52
• 6.7         Some of the Drugs Available in Prefilled Syringes       53
  • 6.7.1      Ovidrel® PreFilled Syringe             53
  • 6.7.2      Enbrel Prefilled Syringes       53
  • 6.7.3      Biocon’s Prefilled Safety Syringes         53
  • 6.7.4      Relistor® Prefilled Syringes            54
  • 6.7.5      PEGASYS®        54
  • 6.7.6      Afluria®              54
  • 6.7.7      Enzira®     55
  • 6.7.8      FluZone® Prefilled Syringe for Children        55
  • 6.7.9      Novolin® N FlexPen Prefilled Insulin Syringe             55
  • 6.7.10    NovoLog® Insulin Prefilled Syringe               55
  • 6.7.11    GlaxoSmithKline’s Vaccines in Prefilled Syringes       56
• 6.8         U.S. Production of Unilife’s Prefilled Syringes             56
• 6.9         Some of the Major Providers of Syringe-Prefilling Services and Products              57
  • 6.9.1      Althea Technologies, Inc.       57
    • 6.9.1.1   Althea’s Clinical Manufacturing       57
    • 6.9.1.2   Althea’s Fill/Finish Services            58
    • 6.9.1.3   Althea’s Contract Manufacturing      58
  • 6.9.2      Baxter International, Inc.        59
    • 6.9.2.1   Baxter’s Contract Manufacturing      60
    • 6.9.2.2   Baxter’s Fill and Finish Capabilities              60
    • 6.9.2.3   Baxter’s Prefilled Syringes Capability           60
    • 6.9.2.4   Baxter’s Vials      61
    • 6.9.2.5   Baxter’s Cartridges            61
  • 6.9.3      Becton, Dickinson and Company      61
    • 6.9.3.1   BD’s Prefilled Syringe Services        62
    • 6.9.3.2   BD Hypak SCF™ Glass Prefillable Syringes           62
    • 6.9.3.3   BD Sterifill SCF™ Plastic Prefillable Syringe Systems             63
    • 6.9.3.4   BD Physioject™ Disposable AutoInjector           63
    • 6.9.3.5   BD™ MicroInfusor™ Automatic Injection System       64
    • 6.9.3.6   BD™ Liquid Dry Injector Disposable Pen Injector         64
    • 6.9.3.7   BD™ Pens Customized Self-Injection Systems             65
    • 6.9.3.8   BD Soluvia™ Prefillable Microinjection System         65
    • 6.9.3.9   BD Preventis™ Shielding System for Prefilled Syringes            66
  • 6.9.4      Catalent Pharma Solutions, Inc.        68
    • 6.9.4.1   The Protector Safety Shield System™            69
    • 6.9.4.2   The ASI™ Autoinjector and Ultra-Compact ASI Mini™ Autoinjector      69
  • 6.9.5      Hyaluron Contract Manufacturing (HCM)       69
    • 6.9.5.1   Hyaluron’s Syringe Filling           69
  • 6.9.6      Vetter Pharma Fertigung GmbH        70
• 6.10       Features of Prefilled Syringes          71
  • 6.10.1    Dual Chamber Prefilled Syringes     71

 

7.           Pen Syringes        72

• 7.1         Pen Devices for Insulin Delivery      73
• 7.2         Technical Advances in Insulin Pens           73
• 7.3         Pen Types and Styles          74
• 7.4         Prefilled Pens      74
• 7.5         Reusable Pens      74
• 7.6         Prefilled Autoinjecting Disposable Syringes      74
• 7.7         Uniject™ Injection Device 75

 

8.           Microneedle         76

• 8.1         Electronic Mosquito           76

 

9.           Needle-free Injectors         77

• 9.1         Needle-free Delivery of Liquids      77
• 9.2         Needle-free Delivery of Solid Formulations  78
• 9.3         Needleless Injector from Injex          79
• 9.4         Jet Syringe from Injex         79
• 9.5         Syrijet    79
• 9.6         PenJet    80
• 9.7         Needle-free Injector for Human Growth Hormone        80

 

10.         Needle and Syringe Market Trends     81

• 10.1       Market Segments                81
• 10.2       Customer Needs         82
• 10.3       Competitor Analysis           82
  • 10.3.1    Automatic Safety Syringes         82
  • 10.3.2    Manually Locking Safety Syringes    83
• 10.4       Third Party Reimbursement              84
• 10.5       Regulation            84
• 10.6       Drug Discovery Trends      85
• 10.7       Demographic Shifts            85
• 10.8       Growth in Home Healthcare             85

 

11.         Technological Developments           87

• 11.1       Auto-Disable Syringes       87
  • 11.1.1    AD Syringes with Needle Retraction/Disposal Feature               88
  • 11.1.2    AD Syringe with No Needle Retraction Feature           88
  • 11.1.3    Needlestick Prevention Syringes      88
  • 11.1.4    Automatic Needlestick Prevention Feature     89
    • 11.1.4.1 UltraSafe®Passive™ Delivery System           89
    • 11.1.4.2 Sterimatic Sleeve®            89
    • 11.1.4.3 K3 Safety Cap      89
• 11.2       Manual Needlestick Prevention Feature          90
  • 11.2.1    Safety Lok™ Syringe         90
  • 11.2.2    Monoject®Magellan™      90

 

12.         Business Trends   91

• 12.1       Market Drivers    91
• 12.2       Market Prospects           92
• 12.3       Marketing and Distribution 93
• 12.4       Competitive Landscape      93
• 12.5       Future Technologies           94
  • 12.5.1    Glide Solid Dose Injector (SDI™)   94
  • 12.5.2    BD Physioject™  94

 

13.         Regulatory Measures          95

• 13.1       Safety Syringes in Europe         95

 

14.         Company Profiles 96

• 14.1       Abbott Laboratories           96
  • 14.1.1    HUMIRA® Prefilled Syringe           96
  • 14.1.2    HUMIRA® Pen       97
  • 14.1.3    Precision Sure-Dose® Insulin Syringes          97
• 14.2       Albert David Limited         98
• 14.3       Alshifa Medical Syringes Manufacturing Company Ltd.              99
• 14.4       Althea Technologies, Inc.       99
• 14.5       Avitro, Inc.           100
• 14.6       Baxter International, Inc.    100
  • 14.6.1    Baxter’s Medication Delivery          100
  • 14.6.2    Baxter’s IV Therapies        101
  • 14.6.3    Baxter’s Global Injectables              101
  • 14.6.4    Baxter’s Infusion Systems       102
  • 14.6.5    Baxter’s IV Infusion Pumps and Infusion Sets 103
  • 14.6.6    Baxter’s Pharma Partnering              103
• 14.7       Becton, Dickinson and Company (BD)           103
  • 14.7.1    BD’s Role in Designing Devices for Safe and Effective Injections and Infusions              103
  • 14.7.2    BD’s Products      103
• 14.8       Boston Scientific Corporation          113
• 14.9       B. Braun 113
  • 14.9.1    The Hospital Care Division              113
  • 14.9.2    The Aesculap Division       114
  • 14.9.3    The Out Patient Market (OPM) Division        114
  • 14.9.4    The B. Braun Avitum Division         115
  • 14.9.5    B. Braun’s Syringe Products             116
• 14.10     Bioject Medical Technologies, Inc.        122
  • 14.10.1  Biojector® 2000  124
  • 14.10.2  Drug Reconstitution System              125
  • 14.10.3  Vitajet®           125
  • 14.10.4  Cool.click™        125
  • 14.10.5  SeroJet™             126
• 14.11     Catalent Pharma Solutions, Inc.        126
  • 14.11.1  Catalent’s Oral Technologies Segment           127
  • 14.11.2  Catalent’s Sterile Technologies Segment        128
  • 14.11.3  Catalent’s Packaging Services Segment          129
  • 14.11.4  Catalent’s Manufacturing Capabilities            130
  • 14.11.5  Catalent’s Employee Strength           130
  • 14.11.6  Catalent’s Syringes             131
• 14.12     C.R. Bard, Inc.     131
  • 14.12.1  Bard’s Vascular Business     131
  • 14.12.2  Bard’s Urology Business       132
  • 14.12.3  Bard’s Oncology Business          133
  • 14.12.4  Bard’s Business in Surgical Specialties         134
  • 14.12.5  Bard’s Overseas Expansion              134
  • 14.12.6  Bard’s Bulb Syringes and Trays       135
  • 14.12.7  Bard’s Piston Syringes and Trays     135
• 14.13     Coeur, Inc.           136
  • 14.13.1  Angiographic Syringes from Coeur, Inc.         136
  • 14.13.2  CT Syringes from Coeur, Inc.           137
• 14.14     Covidien Ltd.       137
  • 14.14.1  Covidien’s Medical Devices Segment            138
  • 14.14.2  Covidien’s R&D      139
  • 14.14.3  Covidien’s Competitors in Medical Devices     139
  • 14.14.4  Covidien’s Syringes           140
• 14.15     Henke-Sass, Wolf GmbH   144
  • 14.15.1  Two-Part Disposable Syringes 1-50(60) ml      144
  • 14.15.2  Three-Part Disposable Syringes 1-30 ml        144
  • 14.15.3  Disposable Needles HSW FINE-JECT®       145
• 14.16     Hindustan Syringes & Medical Devices, Ltd. (HMD)   145
  • 14.16.1  Insulin Syringes from HMD              145
  • 14.16.2  HMD’s Single Use Needles              146
  • 14.16.3  HMD’s Single Use Syringes             147
• 14.17     Hi-Tech Medical Products Ltd.        147
• 14.18     Hyaluron Contract Manufacturing        148
  • 14.18.1  HCM’s Major Markets       148
  • 14.18.2  HCM’s Facility    148
• 14.19     International Medication System Ltd.              149
  • 14.19.1  Delivery Systems from IMS              149
  • 14.19.2  PCA Products from IMS        151
  • 14.19.3  Phytonadione Injection USP              151
  • 14.19.4  Lidocaine HCl Jelly, USP 2% (Preservative-free)        152
• 14.20     Life-Shield Products, Inc.   152
• 14.21     Merit Medical Systems, Inc.             154
  • 14.21.1  Merit’s Products      154
  • 14.21.2  Merit’s Vascular Access Products    154
  • 14.21.3  Merit’s Business in the U.S.             155
  • 14.21.4  Merit’s International Business          156
  • 14.21.5  Merit’s Customers              156
  • 14.21.6  Merit’s R&D        156
  • 14.21.7  Merit’s Manufacturing Facilities      157
• 14.22     Milestone Scientific           157
  • 14.22.1  Milestone Scientific’s Product Platform         158
  • 14.22.2  Milestone Scientific’s Investment in R&D      159
  • 14.22.3  Milestone Scientific’s Business Performance        160
• 14.23     Novo Nordisk A/S             161
  • 14.23.1  Novo Nordisk’s Business in Diabetes Care Segment    161
  • 14.23.2  Novo Nordisk’s Modern Insulins, Human Insulins and Insulin-related Products        162
  • 14.23.3  Novo Nordisk’s Geographic Performance in Diabetes Care Products       163
  • 14.23.4  Pipeline Progress in Nova Nordisk     163
  • 14.23.5  Novo Nordisk’s Modern Insulin Portfolio      164
• 14.24     Owen Mumford Ltd.           166
  • 14.24.1  Owen Mumford’s Global Locations       166
  • 14.24.2  Owen Mumford’s Products 168
• 14.25     Plas-Pak Industries, Inc.     170
  • 14.25.1  Dial-A-Dose® Disposable Veterinary Syringes           170
  • 14.25.2  Dual Syringe and Dental Syringe from Plas-Pak           170
  • 14.25.3  Mini Dual Syringe              170
  • 14.25.4  Manual Dual Syringes        171
• 14.26     Retractable Technologies, Inc.         172
  • 14.26.1  Retractable Technologies’ Principal Products              173
  • 14.26.2  Retractable Technologies’ Principal Markets               173
  • 14.26.3  Retractable Technologies’ R&D      174
  • 14.26.4  Retractable Technologies’ VanishPoint Products          175
• 14.27     Revolutions Medical Corporation    176
  • 14.27.1  Rev Vac Safety Syringe      177
• 14.28     Safety Syringes, Inc.           177
  • 14.28.1  Custom Engineering from Safety Syringes, Inc.             178
  • 14.28.2  Syringe Products from Safety Syringes, Inc.       178
• 14.29     Smiths Medical International/Medex, Inc.       180
  • 14.29.1  Smiths Medical’s Markets      180
  • 14.29.2  Smiths Medical’s Medication Delivery Segment          181
  • 14.29.3  Smiths Medical’s Vital Care Segment             182
  • 14.29.4  Smiths Medical’s Safety Devices Segment         182
  • 14.29.5  Smiths Medical’s Business Performance        182
  • 14.29.6  Smiths Medical’s Business Performance on Geographic Basis   182
  • 14.29.7  Smiths Medical’s R&D      183
  • 14.29.8  Syringes from Smiths Medicals        183
• 14.30     Specialized Health Products International, Inc.             188
  • 14.30.1  SHPI’s Products and Services          189
  • 14.30.2  SHPI’s Licensed Products     190
• 14.31     Star Syringe Ltd.    190
  • 14.31.1  Star Alliances      191
  • 14.31.2  Preoducts from Star Syringe Ltd.      192
• 14.32     Terumo’s Medical Corporation        193
  • 14.32.1  Terumo’s General Hospital Products              193
  • 14.32.2  Terumo’s Diabetes Care Products    194
  • 14.32.3  Terumo’s Syringe Products               195
• 14.33     UltiMed, Inc.        203
  • 14.33.1  UltiCare™ Insulin Syringes              204
  • 14.33.2  UltiCare™ Pen Needles     204
• 14.34     Unilife Medical Solutions, Ltd.        205
  • 14.34.1  Pharmaceutical Market for Unilife’s Prefilled Syringes              205
  • 14.34.2  Unilife Partnership with Sanofi-Aventis         205
  • 14.34.3  Unilife’s Licensing Agreement with Sanofi-Aventis        206
  • 14.34.4  Unilife’s Partnership with Gerresheimer Bünde            206
  • 14.34.5  Unilife’s Portfolio of Safety Syringes             207
  • 14.34.6  Unilife’s Prefilled Syringes              207
  • 14.34.7  Unilife’s Contract Manufacturing Activities   207
  • 14.34.8  Unilife’s Performance in Syringe Market        208
• 14.35     Vetter Pharma-Fertigung GmbH & Co., KG       208
  • 14.35.1  Vetter Services and Solutions           208
  • 14.35.2  Dual-Chamber Technology 209
• 14.36     Vita Needle Company, Inc. 209
  • 14.36.1  Disposable Stainless Steel Needle Blunts from Vita Needle       209
  • 14.36.2  Teflon® Dispensing Needles            210
  • 14.36.3  Vita Needle’s Polypropylene Needles            210
  • 14.36.4  Vita Needle’s Taper Tip Needles     211
• 14.37     West Pharmaceutical Services, Inc.     211
  • 14.37.1  West’s Pharmaceutical Systems Segment        211
  • 14.37.2  West’s Tech Group Segment             212
  • 14.37.3  West’s R&D Activities      213
  • 14.37.4  West’s Syringe Products    214
• 14.38     Wuxi Yushou Medical Appliances Co., Ltd.     217
• 14.39     Ypsomed Holding AG        217
  • 14.39.1  Ypsomed’s Injection Systems           218
  • 14.39.2  Ypsomed’s Insulin Delivery Systems              218
  • 14.39.3  Additional Indication Areas for Pen Systems         218
  • 14.39.4  Ypsomed’s Innovative Injection Systems at a Glance           219
  • 14.39.5  Ypsomed’s Complete Product Range for Insulin Suppliers         219
  • 14.39.6  Ypsomed’s New Dual-Chamber Injecting Systems       220
  • 14.39.7  Ypsomed’s ServoPen         220
  • 14.39.8  Growth of Ypsomed’s Pen Needles     220
  • 14.39.9  Ypsomed’s Performance in 2008/2009           222
  • 14.39.10 Ypsomed’s R&D 223
• 14.40     The Medical House PLC (TMH)      224
  • 14.40.1  TMH’s Products     224

 

Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018           228

• Appendix 2: Syringe Needle Terminology          234
• Appendix 3: Medication Errors and Syringe Safety      236
• Appendix 3.1: Injectable Medication Errors      236
• Appendix 3.2: Frequency of Syringe Usage       236
• Appendix 3.3: Labeling Injectable Medications            236
• Appendix 3.4: Challenges of Labeling            236
• Appendix 3.5: Benefits of a Write-On Stripe 236
• Appendix 3.6: Nurses Influence on Selection of Sharp Devices        237
• Appendix 3.7: Needlestick Injuries    237
• Appendix 3.8: Prevention of Needlestick Injuries         237
• Appendix 3.9: Protection from Needlestick Injuries     238

INDEX OF FIGURES

• Figure 2.1: Principal Causes of Needlestick Injuries        17
• Figure 2.2: Availability of Safety Syringes in the U.S. Healthcare Facilities, 2008 19
• Figure 3.1: Worldwide Unit Market for Syringes and Needles, 2004-2012             26
• Figure 3.2: Global Syringe Market, 2009       26
• Figure 3.3: Worldwide Market for Disposable Syringes and Needl

  Other users found this report page using the following search terms: Syringe prefilled syringes insulin injector pens needleless blood collection syringe market disposable syringes needles insulin prefilled uk needle safety

  If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

  
  

  Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.